What is the current valuation of the US alopecia drugs market as of 2024?

The market valuation was $3800.0 Million in 2024. Read More

What is the projected market size for the US alopecia drugs market by 2035?

The projected valuation for 2035 is $10500.0 Million. Read More

What is the expected CAGR for the US alopecia drugs market during the forecast period 2025 - 2035?

The expected CAGR is 9.68% during the forecast period 2025 - 2035. Read More

Which companies are the key players in the US alopecia drugs market?

Key players include Pfizer Inc, Eli Lilly and Company, Aclaris Therapeutics Inc, Boehringer Ingelheim, Novartis AG, Johnson & Johnson, Amgen Inc, and Merck & Co Inc. Read More

What are the main segments of the US alopecia drugs market?

The main segments include Type, Treatment Type, and End-user. Read More

What was the market size for Alopecia Areata in 2024?

The market size for Alopecia Areata was $1900.0 Million in 2024. Read More

What is the projected market size for Alopecia Totalis by 2035?

The projected market size for Alopecia Totalis is $6750.0 Million by 2035. Read More

Which treatment type had the highest market size in 2024?

In 2024, the treatment type with the highest market size was Alopecia Totalis at $2520.0 Million. Read More

What is the expected market size for home care settings by 2035?

The expected market size for home care settings is $3100.0 Million by 2035. Read More

How does the market size for dermatologic and trichology compare to hospitals in 2024?

In 2024, the market size for dermatologic and trichology was $1950.0 Million, compared to $950.0 Million for hospitals. Read More

US Alopecia Drugs Market

ID: MRFR/Pharma/15190-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Alopecia Drugs Market Research Report: Size, Share, Trend Analysis By Alopecia Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), By Product Type (Tropical, Oral, others) and By End Users (Hospitals and Clinics, Saloons, Home Care) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Million)
  1. 4.1.1 Alopecia Universalis
  2. 4.1.2 Alopecia Areata
  3. 4.1.3 Alopecia Totalis
2. 4.2 Pharmaceutical, BY Treatment Type (USD Million)
  1. 4.2.1 Tropical drugs
  2. 4.2.2 Foams
  3. 4.2.3 Cream
  4. 4.2.4 Lotion
  5. 4.2.5 Oils
  6. 4.2.6 Shampoo
  7. 4.2.7 Gels
  8. 4.2.8 Oral drugs
  9. 4.2.9 Lower level laser therapy
  10. 4.2.10 Platelet-rich therapy
  11. 4.2.11 Hair transplant services
3. 4.3 Pharmaceutical, BY End-user (USD Million)
  1. 4.3.1 Aesthetic clinic
  2. 4.3.2 Hospitals
  3. 4.3.3 Home care setting
  4. 4.3.4 Dermatologic and trichology
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pfizer Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Eli Lilly and Company (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Aclaris Therapeutics Inc (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boehringer Ingelheim (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Novartis AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Johnson & Johnson (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Amgen Inc (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck & Co Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
11. 6.11 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

Alopecia Universalis
Alopecia Areata
Alopecia Totalis

Pharmaceutical By Treatment Type (USD Million, 2025-2035)

Tropical drugs
Foams
Cream
Lotion
Oils
Shampoo
Gels
Oral drugs
Lower level laser therapy
Platelet-rich therapy
Hair transplant services

Pharmaceutical By End-user (USD Million, 2025-2035)

Aesthetic clinic
Hospitals
Home care setting
Dermatologic and trichology

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”